i beg to differ. marth is smart. teva is smart. neither is a joke. the CEO of the company had been saying there would be a high likelihod of approval so i can promise you there was no discrepancy between teva americas and teva global. marth is going to be fine. in fact teva is up significantly since he gave the GS talk so clearly he did his job
how's this for a conspiracy - teva backs off lovenox, and mnta starts to tone down any rhetoric about generic copaxone, both stocks appreciate significantly
just kidding :) teva is up because marth did a good job imo explaining how copaxone won't be cannabalized to a significant degree by oral agents (as well as gave high expectations for their own oral agent)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.